Skip to content

INTERFASE

Active
Private limited companyfounded 2023active for 3 yearsKievitlaan 14, 2820 Bonheiden, BelgiumKBO/BCE: BE 0795.699.215
Summary

INTERFASE has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €216,304 and a net result of €42,444. Equity is growing by about 39% per year across the filed financial years. Its solvency ranks better than 72% of 20,649 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
≈ €150,000turnover 2025, estimated
Staff
≈ 0.1 FTE, estimated
Equity
€216,304
Profit
€42,444
Turnover estimated from the gross margin
Financial health
96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 150 days early
Why 96lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 8.61, cash €106,772Figures for financial year 2025 (filed 07-03-2026)Equity €216,304 (81.1% of total assets)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 72% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100+13
equity 81.1% of total assets
Liquidity 100+18
short-term debt 9.8% · cash 40.0%
Profitability 89-11
return on assets 15.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,148 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025highest value 06-2025: < 0.1%▼ -0.1 percentage points vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity ample (current ratio 8.61, compared with 3.33 in 2024, above the usual 1.5; short-term debt: 9.8% and cash: 40% of total assets), and 18.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 95% on liquidity, 42% on profitability and 68% on growth.

The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 8.61, cash €106,772
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 07-03-2026)
NBB · annual accounts
lowers risk · Equity €216,304 (81.1% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-03-2026, 150 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
150 days early
2024
77 days early
2023
90 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 3 accounts on average 106 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 3 May (3 of the last 3 filed years within 61 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2023.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Weakest financial yearnet €42,444 ▼54.6%
  3. Liquidity more than doubledcurrent ratio 8.61

Financials · financial year 2025, micro format

Turnover
≈ €150,000
Estimated: probably between €120,000 and €190,000
Total assets
€266,630▼ 4.5%
2024 · €279,130
Net result
€42,444▼ 54.6%
2024 · €93,582
Working capital
€199,201▲ 23.6%
2024 · €161,154
Trend over the years

2023 to 2025, 3 financial years

The operating result falls in 2025; 2025 is 57% below 2024 and is the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€51,540 2025 Net result€42,444 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202320242025
Operating result€100,597-€120,905▲ 20.2%€51,540▼ 57.4%
Net result€77,278within the sector's middle half-€93,582within the sector's middle half▲ 21.1%€42,444within the sector's middle half▼ 54.6%
Equity€80,278within the sector's middle half-€173,860within the sector's middle half▲ 117%€216,304within the sector's middle half▲ 24.4%
Total assets€175,342within the sector's middle half-€279,130within the sector's middle half▲ 59.2%€266,630within the sector's middle half▼ 4.5%
Debt€95,063-€105,270▲ 10.7%€50,326▼ 52.2%
Working capital€69,607within the sector's middle half-€161,154within the sector's middle half▲ 132%€199,201within the sector's middle half▲ 23.6%
Solvency45.8%within the sector's middle half-62.3%within the sector's middle half▲ 16.5pp81.1%within the sector's middle half▲ 18.8pp
Current ratio2.46within the sector's middle half-3.33within the sector's middle half▲ 0.878.61above the sector's middle half▲ 5.29
Return on assets (ROA)44.1%above the sector's middle half-33.5%within the sector's middle half▼ 10.5pp15.9%within the sector's middle half▼ 17.6pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €266,630
Fixed assets €41,263 ▼ 15.3%
Current assets €225,367 ▼ 2.2%
Equity and liabilities €266,630
Equity €216,304 ▲ 24.4%
Debt €50,326 ▼ 52.2%
Debt's share of the balance-sheet total falls from 37.7% to 18.9%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€64,511▼
2024 · €132,887
Cash flow
€55,415▼
2024 · €105,563
Debt to equity
0.23▼
2024 · 0.61
ROE
19.6%▼
2024 · 53.8%
Interest coverage
35.34▼
2024 · 58.47
Debt ≤ 1 year
€26,166▼
2024 · €69,247
Debt > 1 year
€24,160▼
2024 · €36,023
Income taxes
€11,046▼
2024 · €25,486
Staff costs
€2,116▲
2024 · €1,947
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.9% are still going.

  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.8% went bankrupt
2.3% stopped otherwise
95.9% still going

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet Code20242025
Assets
Total assets20/58€279,130€266,630▼
Fixed assets21/28€48,729€41,263▼
Tangible fixed assets22/27€48,729€41,263▼
Plant, machinery and equipment23€2,496€1,969▼
Furniture and vehicles24€46,233€39,294▼
Current assets29/58€230,401€225,367▼
Amounts receivable within one year40/41-€90,587
Other amounts receivable41-€90,587
Current investments50/53€85,000€25,000▼
Cash at bank and in hand54/58€92,866€106,772▲
Deferred charges and accrued income490/1€52,535€3,008▼
Equity and liabilities
Total equity and liabilities10/49€279,130€266,630▼
Equity10/15€173,860€216,304▲
Contributions10/11€3,000€3,000=
Reserves13€170,860€213,304▲
Distributable reserves133€170,860€213,304▲
Amounts payable17/49€105,270€50,326▼
Amounts payable after more than one year17€36,023€24,160▼
Financial debts170/4€36,023€24,160▼
Amounts payable within one year42/48€69,247€26,166▼
Current portion of amounts payable after more than one year42€11,380€11,863▲
Trade debts44€1,414€2,144▲
Suppliers440/4€1,414€2,144▲
Taxes, remuneration and social security45€50,530€12,160▼
Taxes450/3€50,530€12,160▼
Other amounts payable47/48€5,923€0▼
Income statement Code20242025
Remuneration, social security and pensions62€1,947€2,116▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11,982€12,971▲
Other operating charges640/8€500€444▼
Gross operating margin9900€135,334€67,071▼
Operating profit (loss)9901€120,905€51,540▼
Financial income75/76B€435€3,775▲
Recurring financial income75€435€3,775▲
Financial charges65/66B€2,273€1,825▼
Recurring financial charges65€2,273€1,825▼
Profit (loss) for the period before taxes9903€119,068€53,490▼
Income taxes67/77€25,486€11,046▼
Profit (loss) for the period9904€93,582€42,444▼
Profit (loss) for the period to be appropriated9905€93,582€42,444▼
Appropriation of the result
Profit (loss) to be appropriated9906€93,582€42,444▼
Transfer to equity691/2€93,582€42,444▼
To other reserves6921€93,582€42,444▼

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202320242025Change
Remuneration, social security and pensions62€1,995€1,947€2,116▲ 8.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,136€11,982€12,971▲ 8.3%
Other operating charges640/8€888€500€444▼ 11.2%
Gross operating margin9900€104,616€135,334€67,071▼ 50.4%
Operating profit (loss)9901€100,597€120,905€51,540▼ 57.4%
Financial income75/76B-€435€3,775▲ 767%
Recurring financial income75-€435€3,775▲ 767%
Financial charges65/66B€455€2,273€1,825▼ 19.7%
Recurring financial charges65€455€2,273€1,825▼ 19.7%
Profit (loss) for the period before taxes9903€100,142€119,068€53,490▼ 55.1%
Income taxes67/77€22,864€25,486€11,046▼ 56.7%
Profit (loss) for the period9904€77,278€93,582€42,444▼ 54.6%
Profit (loss) for the period to be appropriated9905€77,278€93,582€42,444▼ 54.6%
Line202320242025Change
Assets
Total assets20/58€175,342€279,130€266,630▼ 4.5%
Fixed assets21/28€58,075€48,729€41,263▼ 15.3%
Tangible fixed assets22/27€58,075€48,729€41,263▼ 15.3%
Plant, machinery and equipment23-€2,496€1,969▼ 21.1%
Furniture and vehicles24€58,075€46,233€39,294▼ 15.0%
Current assets29/58€117,267€230,401€225,367▼ 2.2%
Amounts receivable within one year40/41--€90,587-
Other amounts receivable41--€90,587-
Current investments50/53€35,000€85,000€25,000▼ 70.6%
Cash at bank and in hand54/58€31,246€92,866€106,772▲ 15.0%
Deferred charges and accrued income490/1€51,020€52,535€3,008▼ 94.3%
Equity and liabilities
Total equity and liabilities10/49€175,342€279,130€266,630▼ 4.5%
Equity10/15€80,278€173,860€216,304▲ 24.4%
Contributions10/11€3,000€3,000€3,000=
Reserves13€77,278€170,860€213,304▲ 24.8%
Distributable reserves133€77,278€170,860€213,304▲ 24.8%
Amounts payable17/49€95,063€105,270€50,326▼ 52.2%
Amounts payable after more than one year17€47,403€36,023€24,160▼ 32.9%
Financial debts170/4€47,403€36,023€24,160▼ 32.9%
Amounts payable within one year42/48€47,660€69,247€26,166▼ 62.2%
Current portion of amounts payable after more than one year42€10,918€11,380€11,863▲ 4.2%
Trade debts44€1,087€1,414€2,144▲ 51.6%
Suppliers440/4€1,087€1,414€2,144▲ 51.6%
Taxes, remuneration and social security45€25,309€50,530€12,160▼ 75.9%
Taxes450/3€25,309€50,530€12,160▼ 75.9%
Other amounts payable47/48€10,347€5,923€0▼ 100%
Line202320242025Change
Profit (loss) for the period9904€77,278€93,582€42,444▼ 54.6%
+ Depreciation and write-downs630€1,136€11,982€12,971▲ 8.3%
Operating cash flow (approximation)€78,414€105,563€55,415▼ 47.5%
Investment in fixed assets (approximation)--€2,635-€5,506▼ 109%
Change in cash-€61,620€13,905▼ 77.4%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (3)
Financial year Type Filed Reference
31-12-2025 micro format 03-03-2026 2026-00050186
31-12-2024 micro format 15-05-2025 2025-00095115
31-12-2023 micro format 02-05-2024 2024-00080322

Similar companies · same sector, comparable size

Of the 16,577 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,126. 6,718 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
1 director, no change since 2023
NOË Esther
Director (not named in the articles) · since 06-01-2023
Current
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Mandate history

1 person since 2023, 1 in office
Show
  • Board
Mandates per person, with start and end dates
Name Functions and periods
NOË Esther
  • Director (not named in the articles), from 06-01-2023 to date
See the board, name and registered office on a given date →

Owners and capital

Capital and shareholders

Shareholders according to the deeds
At incorporation act of 06-01-2023 ↗

The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years
  1. 06-01-2023 Incorporation · €3,000 · 100 shares

Group and network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

History

INTERFASE was incorporated on 4 January 2023 as a private limited company by one natural person, with a starting capital of €3,000.12 The registered office was moved to Bonheiden in 2023.3 Since 2023, NOË Esther has served as director of the company.2 Total assets rose from €175,342 in 2023 to €266,630 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 06-01-2023
  3. 3Belgian Official Gazette, 08-06-2023
  4. 4National Bank, annual accounts 2023 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
03-03
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Weakest financial yearnet €42,444 ▼54.6%
Net result drops to €42,444, the lowest in the series.
31-12
Financial Liquidity more than doubledcurrent ratio 8.61
Current ratio from 3.33 to 8.61; short-term debt falls from €69,247 to €26,166.
31-12
Financial Equity above €200,000equity €216,304 ▲24.4%
A profit in every financial year since 2023 builds equity to €216,304.
15-05
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Highest result from 2023 to 2025net €93,582 ▲21.1%
Operating result €120,905, net result €93,582, both a record.
31-12
Financial Equity above €150,000equity €173,860 ▲117%
A profit in every financial year since 2023 builds equity to €173,860.
02-05
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
08-06
Gazette deed Registered office
Registered-office move · Director in office3 facts ▸
  • General meeting, 24-04-2023
  • Registered-office move, Kievitlaan 14 te 2820 Bonheiden
  • Director in office, Esther NOË (director)
06-01
Gazette deed Incorporation
Appointment: NOË Esther (director) · Founder · Founding capital7 facts ▸
  • Incorporation, “INTERFASE” (deed in Dutch)
  • Founder, NOË Esther
  • Founding capital, €3,000
  • Shareholding, 100
  • Capital
  • Board rule, 1
  • Director appointment, NOË Esther (director (not named in the articles))
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
2 of 2 deeds read

Register details

Identification
Legal formPrivate limited company
Founded04-01-2023
Financial year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0795699215
Also 9925:BE0795699215
Registered 07-05-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 30 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Bonheiden · 1 establishment unit since 2023
registered office establishment The establishment unit on the map
Ground area
1,182 m²
Building footprint
263 m²
Building volume
1,243 m³
Parcel 12005D0117/00K000, Flanders · tallest building 21.1 m. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
INTERFASE
Kievitlaan 14, 2820 BonheidenSpecialist medical practice
since 2023unit no. 2.340.171.817
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
12005D0117/00K000 Flanders 1,181 m² 1 · 263 m² 21.1 m · 1
How the parcels are linked
Good to know
The parcel matches the address exactly.

Articles of association

What the company does

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
INTERFASE
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Vlaams Gewest, Aarschotsesteenweg 552 C,3012 Leuven(Wilsele)” (deed in Dutch)

deed of 06-01-2023

Who represents it, and how

Who signsWho may bind the company towards others, for example by signing a contract.
Each director alone
Board ruleHow the board is made up, meets and takes decisions.
“Om gewichtige redenen geheel of gedeeltelijk herroepbaar door algemene vergadering met vereisten voor statutenwijziging, één of meer…” (deed in Dutch)

deed of 06-01-2023

Capital, shares and profit

Kind of sharesWhich classes of shares exist and what rights each class carries.
“Op naam, register van aandelen op naam” (deed in Dutch)
Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
“Nominale waarde verhoogd met aandeel in reserves zoals blijkt uit laatste neergelegde jaarrekening, elke overdracht onder levenden ten…” (deed in Dutch)
Share issue ruleHow and by whom new shares can be issued.
One provision in the deed

deed of 06-01-2023

Meetings and financial year

Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
Last Thursday of June at 20:00

deed of 06-01-2023

Oversight and winding up

Dissolution ruleWhen and by whom the company can be dissolved.
“Algemene vergadering beslissende in vormen vereist voor statutenwijziging, geval zoals voorzien in artikel 10” (deed in Dutch)
Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
“Algemene vergadering mag één of meerdere vereffenaars aanduiden,bevoegdheden omlijnen en vergoeding bepalen, bestuurder(s) in functie…” (deed in Dutch)

deed of 06-01-2023

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “Statutair onbeschikbare eigen vermogensrekening, inbrengen van de oprichters op onbeschikbare eigen vermogensrekening” (deed in Dutch)
Other provision: “Vergoeding van de bestuurders, tenzij anders beslist door algemene vergadering” (deed in Dutch)
Other provision: “Drie jaar, één of meerdere commissarissen” (deed in Dutch)
Other provision: “Toegang tot algemene vergadering, houder effecten op naam ingeschreven in register effecten op naam voor zijn categorie” (deed in Dutch)
Other provision: “Bestuurder,bij gebrek aanwezige aandeelhouder met meeste aandelen,bij pariteit oudste, Zittingen – processen-verbaal” (deed in Dutch)
Other provision: “Elke aandeelhouder kan ieder ander persoon,al dan niet aandeelhouder,door alle middelen van overdracht schriftelijke volmacht geven…” (deed in Dutch)
Other provision: “Bestuursorgaan tijdens zitting, Verdaging” (deed in Dutch)
Other provision: “Bestemming van de winst – reserves, algemene vergadering” (deed in Dutch)
Liquidation distribution: “Goederen in natura op zelfde wijze verdeeld, bij niet-volgestorte aandelen herstelling evenwicht door bijkomende volstorting of…” (deed in Dutch)
Other provision: “Woonstkeuze, mededelingen,aanmaningen,dagvaardingen en betekeningen geldig” (deed in Dutch)
Other provision: “Rechtbank in wiens rechtsgebied zetel gevestigd, betwisting zaken vennootschap en uitvoering statuten tussen…” (deed in Dutch)
Other provision: “Gemeen recht, strijdig met dwingende bepalingen geacht niet geschreven” (deed in Dutch)
Other provision: “Netting-overeenkomst, alle vorderingen tussen aandeelhouders en/of bestuurders enerzijds en vennootschap anderzijds” (deed in Dutch)
2 more provisions in the deed, see the deed of 06-01-2023

deed of 06-01-2023